Youssoufian Hagop 4
4 · ZIOPHARM ONCOLOGY INC · Filed Jan 3, 2013
Insider Transaction Report
Form 4
Youssoufian Hagop
Executive VP, CMO
Transactions
- Award
Employee Stock Option (right to buy)
2012-12-31+180,000→ 180,000 totalExercise: $4.16Exp: 2022-12-31→ Common Stock (180,000 underlying) - Tax Payment
Common Stock
2012-12-31$4.21/sh−6,919$29,129→ 92,721 total
Footnotes (2)
- [F1]Disposition represents shares withheld to satisfy withholding tax obligations upon the vesting of a restricted stock grant.
- [F2]60,000 shares vest on each of 12/31/2013, 12/31/2014 and 12/31/2015.